BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/105/0.1/20.09.24 Stock BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/105/0.1/20.09.24
Add to a list
To use this feature you must be a member
Log inSign up

BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/105/0.1/20.09.24 Share Price

Warrant

DE000VD0NML4

Market Closed - Deutsche Boerse AG 19:08:36 20/05/2024 BST
0.139 EUR -2.11% Intraday chart for BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/105/0.1/20.09.24
Current month+28.70%
1 month-31.86%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart EDWARDS LIFESCIENCES CORPORATION
Chart BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/105/0.1/20.09.24

Latest news about EDWARDS LIFESCIENCES CORPORATION

Edwards Lifesciences : First Quarter 2024 Fact Sheet PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing MT
Edwards Lifesciences Faces EU Antitrust Complaint By Meril MT
More news

Quotes 5-day view

Date Price Change
20/05/24 0.139 -2.11%
17/05/24 0.142 -19.77%
16/05/24 0.177 +3.51%
15/05/24 0.171 +74.49%
14/05/24 0.098 +6.52%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 07:08 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying EDWARDS LIFESCIENCES CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD0NML
ISINDE000VD0NML4
Date issued 20/02/2024
Strike 105 $
Maturity 20/09/2024 (123 Days)
Parity 10 : 1
Emission price 0.22 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.51 €
Lowest since issue 0.088 €
Delta0x
Omega 0.000000
Premium0x
Gearing85.02x
Moneyness 1.328
Difference Strike 15.22 $
Difference Strike %+14.50%
Spread 0.01 €
Spread %6.41%
Intrinsic value 3.167

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Edwards Lifesciences Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.78 USD
Average target price
95.9 USD
Spread / Average Target
+6.82%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant